All of this disproportionately affects the elderly. In a 2023 study of patients with a median age of 75, approximately 30% of ...

In January 2025, Wockhardt announced that ZAYNICH demonstrated unprecedented efficacy in a global, pivotal Phase III study ...

Credit: Getty Images Researchers conducted a systematic literature review to examine the prevalence of and risk factors for multidrug resistant infections in patients with urinary tract infections.

Cefepime-taniborbactam was 22% more effective than meropenem, which is a current treatment for complicated urinary tract infections (UTIs) and acute pyelonephritis, according to a study published in ...

This guide deconstructs the pathophysiology of UTIs, exploring the anatomical risks in women, and the efficacy of antibiotic ...

GSK has resubmitted its NDA to the FDA for tebipenem HBr, an oral carbapenem for complicated UTIs, backed by positive phase 3 trial results.

A study published in Clinical Infectious Diseases examined independent predictors for treatment failure among patients with complicated urinary tract infections. Researchers conducted a multicenter ...

Compared with meropenem, cefepime-taniborbactam is superior for microbiologic and clinical cure of complicated urinary tract infection, including acute pyelonephritis. Cefepime-taniborbactam is more ...

Please provide your email address to receive an email when new articles are posted on . Oral tebipenem pivoxil hydrobromide is noninferior to IV ertapenem for the treatment of complicated UTI and ...

Carbapenem-resistant Enterobacterales and multidrug-resistant Pseudomonas aeruginosa are a global threat to antimicrobial resistance and may be causative pathogens in cUTI. Cefepime-taniborbactam ...

A constant urge to use the restroom that results in a burning sensation when urinating likely means you have a urinary tract infection (UTI). Often painful and uncomfortable (to say the least), ...

Cefepime-taniborbactam, an investigational beta-lactam and beta-lactamase inhibitor combination, was superior to meropenem for the treatment of hospitalized patients with complicated urinary tract ...